Beyond the intratumoral immune landscape: lymph node heterogeneity and systemic immune networks shape responses to cancer immunotherapy

Immune checkpoint blockade (ICB) has transformed cancer therapy, yet clinical benefit remains highly heterogeneous. Although the intratumoral immune landscape is central to understanding ICB efficacy, peripheral T-cell clonal dynamics highlight the importance of immune processes beyond the tumor microenvironment. Lymph nodes (LNs), particularly tumor-draining lymph nodes (TDLNs), contribute to systemic antitumor immunity through antigen presentation, T-cell priming, and the maintenance of tumor-reactive precursor populations. However, LNs are not functionally equivalent. In this Review, we examine the multiscale determinants of LN heterogeneity, including intranodal organization, tissue-specific immune imprinting, and regional lymphatic connectivity, and discuss tumor-induced remodeling and treatment-associated changes in LN function. We then consider the implications of LN heterogeneity for systemic antitumor immunity, immunotherapy responses, and potential clinical applications, including biomarker development and LN-directed therapeutic strategies. Finally, we propose testable hypotheses to guide future mechanistic and clinical investigations.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.1983466
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond the intratumoral immune landscape: lymph node heterogeneity and systemic immune networks shape responses to cancer immunotherapy

Shengpeng Ma, Di Liu, Li Tang
2 links
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Beyond the intratumoral immune landscape: lymph node heterogeneity and systemic immune networks shape responses to cancer immunotherapy

Shengpeng Ma, Di Liu, Li Tang
article en

Abstract

Immune checkpoint blockade (ICB) has transformed cancer therapy, yet clinical benefit remains highly heterogeneous. Although the intratumoral immune landscape is central to understanding ICB efficacy, peripheral T-cell clonal dynamics highlight the importance of immune processes beyond the tumor microenvironment. Lymph nodes (LNs), particularly tumor-draining lymph nodes (TDLNs), contribute to systemic antitumor immunity through antigen presentation, T-cell priming, and the maintenance of tumor-reactive precursor populations. However, LNs are not functionally equivalent. In this Review, we examine the multiscale determinants of LN heterogeneity, including intranodal organization, tissue-specific immune imprinting, and regional lymphatic connectivity, and discuss tumor-induced remodeling and treatment-associated changes in LN function. We then consider the implications of LN heterogeneity for systemic antitumor immunity, immunotherapy responses, and potential clinical applications, including biomarker development and LN-directed therapeutic strategies. Finally, we propose testable hypotheses to guide future mechanistic and clinical investigations.

Frontiers in ImmunologyVol. 17
Academy of Military Medical Sciences (CN)
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon